Technology

  • Patented ElectroNanospray™ (ENS) platform
  • Multijet nozzle arrays support lab scale through commercial production
  • Proprietary nozzle design enables the development of customizable particles

Unique Particle Design

  • Amorphous
  • Small (nanometer to micron)
  • Uniform

Process

  • Operates at ambient conditions
  • Non-destructive to sensitive APIs and biologics
  • Uses standard pharmaceutical solvents and excipients

Scale of production

  • Supports full range of preclinical development
  • CRO/CMO partnership established to support pilot and commercial-scale operation